Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 24 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 10647754

    Stabilized single human CD4 domains and fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 12, 2020 · Expires May 7, 2040

    granted

  2. US 10646588

    RP2 and RPGR vectors for treating X-linked retinitis pigmentosa

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 12, 2020 · Expires May 7, 2040

    granted

  3. US 10646591

    Imaging agents for imaging protease activity and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 12, 2020 · Expires May 7, 2040

    granted

  4. US 10640571

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 5, 2020 · Expires Apr 30, 2040

    granted

  5. US 10640771

    Compositions and methods for treating and preventing macular degeneration

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE · Granted May 5, 2020 · Expires Apr 30, 2040

    granted

  6. US 10632185

    Chimeric west nile/zika viruses and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  7. US 10633447

    Soluble engineered monomeric Fc

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  8. US 10611815

    T cell receptors recognizing MHC class II-restricted MAGE-A3

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  9. US 10611816

    Anti-KRAS-G12D T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  10. US 10604582

    Anti-CD276 antibodies (B7H3)

    The United States of America, as represented by the Secretary, Department of Health · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  11. US 10604548

    Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  12. US 10604499

    MYC G-quadruplex stabilizing small molecules and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  13. US 10596185

    Flavonoid compositions and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted

  14. US 10588984

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted

  15. US 10590074

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted

  16. US 10583173

    Methods of treating or preventing pruritis by blocking natriuretic polypeptide b

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  17. US 10584355

    Chimpanzee adenoviral vector-based filovirus vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  18. US 10584161

    Monoclonal antibodies specific for heartland virus and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  19. US 10577349

    Quinolinones as inhibitors of translation initiation complex

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted

  20. US 10576059

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    The United States of America, as Represented by the Secretary, Department of Human Services · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted

  21. US 10577368

    A3 adenosine receptor agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted

  22. US 10570172

    Self-assembling amphiphilic peptides

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  23. US 10568956

    Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  24. US 10570214

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.